Bright Green Corporation (BGXX)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -8.89 Million USD | 60.49% |
| 2022 | -27.31 Million USD | -996.72% |
| 2021 | -2.49 Million USD | 12.46% |
| 2020 | -2.84 Million USD | -226.85% |
| 2019 | -870.47 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.52 Million USD | 18.85% |
| 2024 Q1 | -1.87 Million USD | -26.82% |
| 2023 Q3 | -1.95 Million USD | 34.53% |
| 2023 FY | -10.79 Million USD | 60.49% |
| 2023 Q4 | -1.48 Million USD | 24.27% |
| 2023 Q1 | -2.61 Million USD | -60.34% |
| 2023 Q2 | -2.98 Million USD | -14.31% |
| 2022 Q2 | -12.88 Million USD | -1673.69% |
| 2022 Q1 | -726.34 Thousand USD | 21.16% |
| 2022 FY | -27.31 Million USD | -996.72% |
| 2022 Q4 | -1.62 Million USD | 71.79% |
| 2022 Q3 | -5.77 Million USD | 55.16% |
| 2021 Q4 | -921.29 Thousand USD | -46.65% |
| 2021 FY | -2.49 Million USD | 12.46% |
| 2021 Q3 | -628.21 Thousand USD | -45.6% |
| 2021 Q2 | -431.47 Thousand USD | 15.32% |
| 2021 Q1 | -509.54 Thousand USD | 13.65% |
| 2020 FY | -2.84 Million USD | -226.85% |
| 2020 Q4 | -590.1 Thousand USD | 52.12% |
| 2020 Q3 | -1.23 Million USD | -50.19% |
| 2020 Q2 | -820.63 Thousand USD | -45.72% |
| 2020 Q1 | -563.15 Thousand USD | 0.0% |
| 2019 FY | -870.47 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| BioQuest Corp. | -89.76 USD | -9905626.381% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | 42.982% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 116.634% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | -105.045% |
| GSRX Industries Inc. | - USD | Infinity% |
| High Sierra Technologies, Inc. | -238.36 Thousand USD | -3630.169% |
| Instadose Pharma Corp. | - USD | Infinity% |